Compare WASH & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WASH | IRWD |
|---|---|---|
| Founded | 1800 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 696.1M | 741.8M |
| IPO Year | N/A | 2010 |
| Metric | WASH | IRWD |
|---|---|---|
| Price | $35.47 | $4.57 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $31.25 | $3.68 |
| AVG Volume (30 Days) | 147.0K | ★ 2.7M |
| Earning Date | 01-28-2026 | 02-17-2026 |
| Dividend Yield | ★ 6.26% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.71 | 0.18 |
| Revenue | $219,848,000.00 | ★ $338,987,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.00 | $37.22 |
| P/E Ratio | ★ $13.20 | $25.07 |
| Revenue Growth | ★ 123.76 | N/A |
| 52 Week Low | $24.95 | $0.53 |
| 52 Week High | $37.08 | $5.78 |
| Indicator | WASH | IRWD |
|---|---|---|
| Relative Strength Index (RSI) | 66.39 | 51.38 |
| Support Level | $35.30 | $4.42 |
| Resistance Level | $37.08 | $4.91 |
| Average True Range (ATR) | 1.18 | 0.32 |
| MACD | 0.18 | -0.09 |
| Stochastic Oscillator | 78.55 | 33.49 |
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.